- Home
- MRTN vs PRAX Comparison
MRTN vs PRAX Comparison
Compare MRTN & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRTN
- PRAX
- Stock Information
- Founded
- MRTN 1946
- PRAX 2015
- Country
- MRTN United States
- PRAX United States
- Employees
- MRTN N/A
- PRAX N/A
- Industry
- MRTN Trucking Freight/Courier Services
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- MRTN Industrials
- PRAX Health Care
- Exchange
- MRTN Nasdaq
- PRAX Nasdaq
- Market Cap
- MRTN 1.1B
- PRAX 950.8M
- IPO Year
- MRTN 1986
- PRAX 2020
- Fundamental
- Price
- MRTN $12.35
- PRAX $49.05
- Analyst Decision
- MRTN Buy
- PRAX Strong Buy
- Analyst Count
- MRTN 2
- PRAX 10
- Target Price
- MRTN $19.00
- PRAX $102.00
- AVG Volume (30 Days)
- MRTN 648.4K
- PRAX 586.8K
- Earning Date
- MRTN 07-16-2025
- PRAX 08-04-2025
- Dividend Yield
- MRTN 1.95%
- PRAX N/A
- EPS Growth
- MRTN N/A
- PRAX N/A
- EPS
- MRTN 0.25
- PRAX N/A
- Revenue
- MRTN $920,872,000.00
- PRAX $7,765,000.00
- Revenue This Year
- MRTN N/A
- PRAX N/A
- Revenue Next Year
- MRTN $5.04
- PRAX $3,567.38
- P/E Ratio
- MRTN $49.35
- PRAX N/A
- Revenue Growth
- MRTN N/A
- PRAX 338.45
- 52 Week Low
- MRTN $11.58
- PRAX $26.70
- 52 Week High
- MRTN $18.63
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- MRTN 47.08
- PRAX 47.31
- Support Level
- MRTN $11.58
- PRAX $44.25
- Resistance Level
- MRTN $12.22
- PRAX $53.46
- Average True Range (ATR)
- MRTN 0.32
- PRAX 3.81
- MACD
- MRTN -0.00
- PRAX -1.11
- Stochastic Oscillator
- MRTN 47.83
- PRAX 28.61
About MRTN Marten Transport Ltd.
Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.